Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iteos Therapeutics Inc (NQ: ITOS )

16.44 -1.61 (-8.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,029
Open 18.05
Bid (Size) 16.20 (1)
Ask (Size) 17.90 (1)
Prev. Close 18.05
Today's Range 16.19 - 18.20
52wk Range 12.52 - 28.05
Shares Outstanding 35,763,742
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga

Performance

YTD
-11.33%
-11.33%
1 Month
+16.84%
+16.84%
3 Month
-7.17%
-7.17%
6 Month
-15.35%
-15.35%
1 Year
-6.06%
-6.06%

More News

Read More
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ITeos Therapeutics: Q1 Earnings Insights
Via Benzinga
Looking Into ITeos Therapeutics's Return On Invested Capital
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
Via Benzinga
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
Via Investor's Business Daily
iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
The 7 Most Undervalued Stocks You Need to Know About
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
7 Small-Cap Stocks That Are Flying Under the Radar
Via InvestorPlace
7 Dirt-Cheap Stocks Sitting in the Sweet Spot
Via InvestorPlace
iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
The Top 7 Growth Stocks in Biotech
Via InvestorPlace
iTeos to Present at Cowen 43rd Annual Health Care Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
iTeos to Present at SVB Securities Global Biopharma Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Via InvestorPlace
iTeos Provides Business Updates and Clinical Development Plans for 2023
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.